What question did this study set out to answer?

To compare the efficacy and clinical outcomes of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients without heart failure.

January 1, 2013Rational Pharmacotherapy in CardiologyOpen Access

A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patientswithout Heart Failure

View Full Paper

Ask AI

Bookmark

Key result

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were evaluated for their clinical effects in patients without heart failure.

Key Points

To compare the efficacy and clinical outcomes of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients without heart failure.
Meta-analysis pooling randomized controlled trials assessing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs).
Analyzed major cardiovascular outcomes and mortality exclusively in patient cohorts without heart failure.
Angiotensin-converting enzyme inhibitors significantly reduced all-cause mortality, cardiovascular death, and myocardial infarction risk.
Angiotensin receptor blockers demonstrated no statistically significant reduction in all-cause mortality or cardiovascular mortality compared to control regimens.

Implication

Informs ACEI/ARB decisions in non-HF patients; extends meta-analytic evidence beyond heart failure populations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Savarese et al. (2013) studied this question. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were evaluated for their clinical effects in patients without heart failure.

synapsesocial.com/papers/6a0ebdb1b9cfc04f9247a562 https://doi.org/10.20996/1819-6446-2013-9-2-188-200